semaglutide canada patent Ozempic's problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Semaglutide generics flood Indian market

Learn what FDA data shows about neurological side effects, when to contact your doctor, and how to manage symptoms during GLP-1 treatment.

Semaglutide the active ingredient in Ozempic, Wegovy, and Rybelsus can reduce your appetite and curb food cravings to promote weight loss.

A woman with lupus shares her experience with being prescribed semaglutide for weight loss, and the pros and cons of this new medication.

Patent law is only one part of a much broader equation.The growing burden of diabetes across Africa provides an opportunity to rethink how intellectual property, public health and industrial policy interact before the continent faces another access crisis.The legal tools already exist.The more difficult question is whether governments are prepared to use them and whether the international community is willing to support a model of pharmaceutical innovation that rewards research while recognising that access to essential medicines is, ultimately, a matter of public interest.This is a co-published article, originally published on WIPR.

Check out Shawns incredible results using GLP-1 treatment in just 24 days

However, its benefits extend beyond the scale, offering remarkable psychological and emotional advantages